# Daewon Pharmaceutical Co., Ltd.

Organization · id `cardio:org-daewon-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Daewon+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Daewon Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia (`cardio:ct-nct02390375`)
- Sponsors: A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure (`cardio:ct-nct02681952`)
- Sponsors: Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure. (`cardio:ct-nct02681991`)
- Sponsors: Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia (`cardio:ct-nct03210532`)
- Sponsors: Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy (`cardio:ct-nct03874260`)
- Sponsors: Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A (`cardio:ct-nct05970679`)
- Sponsors: Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (`cardio:ct-nct06767774`)
- Sponsors: Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 (`cardio:ct-nct07076056`)

## Provenance

Content hash: 3e33f2568428146b2b02670d44594fdb1e2c5b3333ca160e8468fed0c3480dbf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
